No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration–Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus-Reference-Cited by-同舟云学术

No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration–Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus

Published:2022-03 Issue:2 Volume:54 Page:286-292
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Endo Takahito,Ishimura Takeshi,Nishioka Shun,Yokoyama Naoki,Ogawa Satoshi,Fujisawa Masato

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference29 articles.

1. Reduced exposure to calcineurin inhibitors in renal transplantation;Ekberg;N Engl J Med,2007

2. Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study;Eisenberger;BMC Nephrol,2018

3. Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation;Mjörnstedt;Transpl Int,2015

4. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study;Lebranchu;Am J Transplant,2009

5. Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor specific antibody development;Wiebe;J Am Soc Nephrol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease;IJU Case Reports;2022-06-24